DrugPatentWatch Database Preview
CALCITONIN-SALMON Drug Profile
» See Plans and Pricing
Which patents cover Calcitonin-salmon, and when can generic versions of Calcitonin-salmon launch?
Calcitonin-salmon is a drug marketed by Igi Labs Inc, Apotex Inc, and Par Pharm. and is included in three NDAs.
The generic ingredient in CALCITONIN-SALMON is calcitonin salmon. There are fourteen drug master file entries for this compound. Three suppliers are listed for this compound. Additional details are available on the calcitonin salmon profile page.
Summary for CALCITONIN-SALMON
| US Patents: | 0 |
| Applicants: | 3 |
| NDAs: | 3 |
| Suppliers / Packagers: | 2 |
| Bulk Api Vendors: | 13 |
| Clinical Trials: | 22 |
| Formulation / Manufacturing: | see details |
| Drug Prices: | Drug price information for CALCITONIN-SALMON |
| DailyMed Link: | CALCITONIN-SALMON at DailyMed |
Recent Clinical Trials for CALCITONIN-SALMON
Identify potential brand extensions & 505(b)(2) entrants
| Sponsor | Phase |
|---|---|
| University of Missouri-Columbia | Phase 4 |
| University of Maryland | Phase 4 |
| Tarsa Therapeutics, Inc. | Phase 3 |
Pharmacology for CALCITONIN-SALMON
| Drug Class | Calcitonin |
US Patents and Regulatory Information for CALCITONIN-SALMON
| Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Exclusivity Expiration |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Igi Labs Inc | CALCITONIN-SALMON | calcitonin salmon | INJECTABLE;INJECTION | 073690-001 | Apr 14, 1995 | DISCN | No | No | Start Trial | Start Trial | Start Trial | ||||
| Apotex Inc | CALCITONIN-SALMON | calcitonin salmon | SPRAY, METERED;NASAL | 076396-001 | Nov 17, 2008 | AB | RX | No | Yes | Start Trial | Start Trial | Start Trial | |||
| Par Pharm | CALCITONIN-SALMON | calcitonin salmon | SPRAY, METERED;NASAL | 076979-001 | Jun 8, 2009 | AB | RX | No | No | Start Trial | Start Trial | Start Trial | |||
| >Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >TE | >Type | >RLD | >RS | >Patent No. | >Patent Expiration | >Product | >Substance | >Delist Req. | >Exclusivity Expiration |
